ClinicalTrials.govpublic full text
Safety of TY027, a Treatment for COVID-19, in Humans
coronavirus disease-2019 (covid-19), coronavirus disease-2019, covid-19, sars-cov-2, monoclonal antibody, infectious diseases, phase 1 first in human study, singapore, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830242
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.